Cerity Partners LLC Invests $884,000 in Viking Therapeutics, Inc ...

Dec 6, 2024 · Cerity Partners LLC bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 3rd quarter, according to its most recent 13F filing with …

$884000
OFF

Cerity Partners LLC Invests $884,000 In Viking Therapeutics, Inc ...

2 weeks from now

Dec 6, 2024 · Cerity Partners LLC bought a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 3rd quarter, according to its most recent 13F filing with …

marketbeat.com

$211464000
OFF

Repligen Co. (NASDAQ:RGEN) Shares Purchased By Cerity Partners …

2 weeks from now

Dec 6, 2024 · Champlain Investment Partners LLC now owns 1,420,935 shares of the biotechnology company’s stock valued at $211,464,000 after purchasing an additional …

defenseworld.net

6%
OFF

Cerity Partners LLC Buys 6,685 Shares Of Invitation Homes Inc.

2 weeks from now

Dec 6, 2024 · Cerity Partners LLC increased its position in shares of Invitation Homes Inc. (NYSE:INVH – Free Report) by 43.6% during the 3rd quarter, according to its most recent …

defenseworld.net

$0.34
OFF

Oak Ridge Investments LLC Acquires New Stake In Viking …

2 weeks from now

Nov 2, 2024 · Viking Therapeutics Stock Up 0.5 %. VKTX stock traded up $0.34 on Friday, reaching $72.88. 3,171,048 shares of the company's stock were exchanged, compared to its …

marketbeat.com

0%
OFF

Cerity Partners LLC Purchases 900 Shares Of Moderna, Inc.

2 weeks from now

Dec 6, 2024 · Cerity Partners LLC boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.0% during the 3rd quarter, according to its most recent …

defenseworld.net

$999000
OFF

Nvwm LLC Takes $999,000 Position In Viking Therapeutics, Inc.

2 weeks from now

Nov 3, 2024 · Nepsis Inc. acquired a new position in shares of Viking Therapeutics during the 3rd quarter worth approximately $11,251,000. CWM LLC raised its stake in Viking Therapeutics by …

marketbeat.com

4%
OFF

Match Group, Inc. (NASDAQ:MTCH) Shares Purchased By Cerity …

2 weeks from now

Dec 2, 2024 · Cerity Partners LLC lifted its stake in shares of Match Group, Inc. (NASDAQ:MTCH – Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent …

defenseworld.net

0%
OFF

Chartwell Investment Partners LLC Acquires 17,159 Shares Of …

2 weeks from now

Nov 13, 2024 · Chartwell Investment Partners LLC grew its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 88.0% during the third quarter, …

marketbeat.com

FAQs about Cerity Partners LLC Invests $884,000 in Viking Therapeutics, Inc ... Coupon?

Does Cerity Partners LLC own Viking Therapeutics?

Cerity Partners LLC acquired a new stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 13,969 shares of the biotechnology company’s stock, valued at approximately $884,000. ...

Does signaturefd LLC own Viking Therapeutics?

Signaturefd LLC lifted its position in Viking Therapeutics by 16.2% in the 3rd quarter. Signaturefd LLC now owns 1,351 shares of the biotechnology company’s stock worth $86,000 after buying an additional 188 shares during the last quarter. ...

Is Viking Therapeutics a buy?

Riley began coverage on shares of Viking Therapeutics in a report on Friday, November 22nd. They set a “buy” rating and a $109.00 price target for the company. Finally, HC Wainwright reissued a “buy” rating and issued a $102.00 price target on shares of Viking Therapeutics in a report on Tuesday, November 26th. ...

Does FSB ADV own Viking Therapeutics?

Massmutual Trust Co. FSB ADV grew its holdings in shares of Viking Therapeutics by 84.3% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 553 shares of the biotechnology company’s stock valued at $35,000 after purchasing an additional 253 shares during the last quarter. ...

Should you buy Viking Therapeutics (vktx)?

One analyst has rated the stock with a sell rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Viking Therapeutics presently has a consensus rating of “Buy” and a consensus price target of $106.75. Check Out Our Latest Research Report on VKTX ...